These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 12777580)

  • 1. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
    Biroscak BJ; Fiore AE; Fasano N; Fineis P; Collins MP; Stoltman G
    Pediatrics; 2003 Jun; 111(6 Pt 1):e645-9. PubMed ID: 12777580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
    Thomas AR; Fiore AE; Corwith HL; Cieslak PR; Margolis HS
    Pediatr Infect Dis J; 2004 Apr; 23(4):313-8. PubMed ID: 15071284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):94-7. PubMed ID: 11263794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage.
    Luman ET; Fiore AE; Strine TW; Barker LE
    JAMA; 2004 May; 291(19):2351-8. PubMed ID: 15150207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women.
    Ko SC; Schillie SF; Walker T; Veselsky SL; Nelson NP; Lazaroff J; Crowley S; Dusek C; Loggins K; Onye K; Fenlon N; Murphy TV
    Vaccine; 2014 Apr; 32(18):2127-33. PubMed ID: 24560676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Perinatal Transmission of Hepatitis B Virus: Assessment Among Wisconsin Maternity Hospitals.
    Borchardt SM; Kocharian A; Hopfensperger D; Davis JP
    WMJ; 2016 Apr; 115(2):74-9; quiz 80. PubMed ID: 27197340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA.
    Zhao Z; Murphy TV; Jacques-Carroll L
    Vaccine; 2011 Dec; 30(1):14-20. PubMed ID: 22063390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of perinatal transmission of the hepatitis B virus. Outcome of infants in a community prevention program.
    Niu MT; Targonski PV; Stoll BJ; Albert GP; Margolis HS
    Am J Dis Child; 1992 Jul; 146(7):793-6. PubMed ID: 1496944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal Screening for and Prevalence of Hepatitis B Surface Antigen in Pregnant Women and Prevention of Transmission to Infants Born to Infected Mothers-Guam, 2014.
    Abara WE; Cha S; Malik T; DeSimone MS; Schillie S; Collier M; Schumann B; Klemme M; Kamb M
    J Pediatric Infect Dis Soc; 2018 Dec; 7(4):290-295. PubMed ID: 28992071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010.
    Kunoee A; Nielsen J; Cowan S
    Euro Surveill; 2016; 21(7):pii=30136. PubMed ID: 26923681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaps in hospital policies and practices to prevent perinatal transmission of hepatitis B virus.
    Willis BC; Wortley P; Wang SA; Jacques-Carroll L; Zhang F
    Pediatrics; 2010 Apr; 125(4):704-11. PubMed ID: 20211952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of perinatal hepatitis B virus infections among a high risk population: the delivery hospital as a safety net.
    Fischer G; Wang S; Ahring S; Fowler K; Hainline S; Chinglong M; Jacques-Carroll L; Bell B; Williams I
    Pediatr Infect Dis J; 2009 Jul; 28(7):593-7. PubMed ID: 19455073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation.
    Cui F; Luo H; Wang F; Zheng H; Gong X; Chen Y; Wu Z; Miao N; Kane M; Hennessey K; Hadler SC; Hutin YJ; Liang X; Yang W
    Vaccine; 2013 Dec; 31 Suppl 9():J36-42. PubMed ID: 24331019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.